News & Press


FDA Approves Atezolizumab to Treat BRAF V600 Unresectable or Metastatic Melanoma

July 31, 2020

Washington, DC, July 31, 2020 – On July 30, 2020, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.) in combination with cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresec …



House Appropriations Committee Includes $20 million for Defense-funded Melanoma Research

July 21, 2020

Washington, DC, July 21, 2020 – The Melanoma Research Foundation (MRF) commends the House Appropriations Committee for including $20 million for Department of Defense (DoD)-funded melanoma research in its Fiscal 2021 Department of Defense Appropriation …



House Appropriations Committee Approves Funding for Fiscal 2021 Labor, Health and Human Services Bill

July 13, 2020

Washington, DC, July 13, 2020 – Today the House Appropriations Committee approved its version of the Fiscal 2021 Labor, Health and Human Services (LHHS) Appropriations bill. The House bill provides $47 billion for the National Institutes of Health (NIH …



Governor DeSantis of Florida Signs Sunscreen Bill

July 7, 2020

Washington, DC, July 7, 2020 – On June 29, 2020, Governor Ron DeSantis of Florida signed Florida Senate Bill (SB) 172, which would overturn current and future bans and other actions related to the use of certain widely used sunscreen ingredients. These …



A Commitment to Our Community

June 11, 2020

June 11, 2020 – The Melanoma Research Foundation (MRF) was founded in 1996 by Diana Ashby, a young woman who was frustrated that, despite significant advances in other forms of cancer, melanoma patients like herself lacked effective treatment options. …